-
Mashup Score: 0After four years of treatment for stage 4 cancer I just wanted some encouraging words from my oncologist - 1 year(s) ago
My oncologist has one of those little motivational prints hanging on his waiting room wall, with the simple statement: “trust your instincts.” One day, bored with the long purgatory of the waiting room, I tweet this news to the world with the observation: “If I trusted my instincts, I’d run screaming from this place and never come back.”
Source: medicalxpress.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 2Source: link.springer.comCategories: Latest Headlines, Oncologists2Tweet
-
Have a look at our latest publication! Amivantamab vs Real-World Clinical Practice in Europe and USA for #EGFR #Ex20ins #NSCLC https://t.co/djPUZ3LoFe
-
-
Mashup Score: 1AEACaP - UOMI - 1 year(s) ago
FacebookTweetPinLinkedInEmail El proyecto Prescripción de ejercicio físico en el paciente con cáncer de pulmónliderado por la The Ricky Rubio Foundation y dirigida por el Dr. Santiago Viteri de UOMI Cancer Center,ha sido seleccionado como uno de los ganadores de la edición 2022 de las becas Dulce López – Fabrizio Facchini de la AEACaP El presente […]Leer más… from AEACaP
Source: UOMICategories: Latest Headlines, Oncologists2Tweet-
¡Tremendamente agradecidos! "Prescripción de ejercicio físico en el paciente con cáncer de pulmón" by @TRRFoundation + #UOMI, ha sido seleccionado para una de las becas Dulce López - Fabrizio Facchini de @AEACaP de la edición 2022 https://t.co/VG2pKEozkX
-
-
Mashup Score: 0Santiago Viteri on LinkedIn: #cáncerdemama - 2 year(s) ago
¡Explora’t! El 19 de octubre es el día del #cáncerdemama y como sabeis para su detección precoz la autoexploración es fundamental. Por eso, la Dra Marta…
Source: www.linkedin.comCategories: Latest Headlines, Oncologists2Tweet-
https://t.co/qbQ0ELAVmH
-
-
Mashup Score: 4Doppelgängers Similar in Looks and DNA: Study - 2 year(s) ago
Look-alikes are also more likely to share lifestyle traits.
Source: The Scientist Magazine®Categories: Latest Headlines, Oncologists2Tweet-
RT @ManelEsteller: Doppelgängers Similar in Looks and DNA: Study https://t.co/coJZCGMWyM
-
-
Mashup Score: 0Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors - 2 year(s) ago
Treatment with immune checkpoint inhibitors (ICIs) have led to longer remissions and overall survival in patients with NSCLC, with 5-year survival rates of approximately 15% to 30% in advanced disease, as second- and first-line treatment, respectively.1, 2 However, not all patients will respond to ICIs due to primary or acquired resistance.3
Source: Clinical Lung CancerCategories: Latest Headlines, Oncologists2Tweet-
EGFR Ex20ins patients appear to less responsive to PD1/PDl1 Inhibition. “Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors” https://t.co/ScEpTm4Zpm
-
-
Mashup Score: 3
BackgroundCIMAvax-EGF is an epidermal growth factor (EGF)-depleting immunotherapy which has shown survival benefit as a switch maintenance treatment after platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC). The primary objective of this trial is to establish the safety and recommended phase II dose (RP2D) of CIMAvax-EGF in combination with nivolumab as second-line therapy…
Source: FrontiersCategories: Latest Headlines, Oncologists2Tweet-
Nivolumab + CimaVAX-EGF combo seems to be safe and potentially synergistic in this article reporting results of a phase I trial https://t.co/dohPB3H2mT
-
-
Mashup Score: 2
Cabozantinib is approved, in various settings, for the treatment of renal cell carcinoma, medullary thyroid cancer, and hepatocellular carcinoma, and it has been investigated for the treatment of other cancers. With the available evidence and the real-world …
Source: PubMed Central (PMC)Categories: Latest Headlines, Oncologists2Tweet-
After lots of work, this systematic review on Cabozantinib is finally published. Very happy to be on the author list with top oncologists as @Maroto5Pablo and @Ja_Capdevila https://t.co/ytATnDsjqU #Cabozantinib #Cancer #UOMI
-
-
Mashup Score: 5
Background The survival of patients with lung cancer has substantially increased in the last decade by about 15%. This increase is, basically, due to targeted therapies available for advanced stages and the emergence of immunotherapy itself. This work aims to study the situation of biomarker testing in Spain. Patients and methods The Thoracic Tumours Registry (TTR) is an observational,…
Source: BioMed CentralCategories: Latest Headlines, Oncologists2Tweet-
RT @MARIANOPROVENCI: https://t.co/3V55bYSrZ6
-
-
Mashup Score: 0Registration S&S Virtual - Registration Form for virtual attendance: Science & Society Session - 2 year(s) ago
You are about to register for virtual attendance: Science & Society Session of the 4th International Conference of the Trisomy 21 Research Society to be held from 9 to 12 June 2022 in Long Beach, California.Please fill the required fields (*) with the requested information for each section and then click the ‘Next’ button (on the navigation bar at the bottom) to proceed to the next…
Source: barcelo.eventsair.comCategories: Latest Headlines, Oncologists2Tweet-
Free registration here! https://t.co/BU3XiEeLZN https://t.co/Dy1eRzOjVt
-
"The current model of cancer care serves no one's best interests, leaving complex patient needs unmet and exacting a cruel toll on clinicians" https://t.co/avZWu32kVl via @medical_xpress